Other uses of Depakote ER
Besides the treatment of seizures, Depakote ER is also FDA-approved for the prophylaxis of migraine headaches (not acute treatment). (This was the initial indication for Depakote ER.)
Depakote ER is also FDA-approved for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features.
Possible harm to the fetus should be considered before Depakote ER is prescribed for women of childbearing potential. (See Pregnancy.)
